Protocol for microglia replacement by peripheral blood (Mr PB)

Zhen Xu1, Yanxia Rao2, Bo Peng3

  • 1Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.

STAR Protocols
|June 28, 2021
PubMed

Insights

Peripheral blood cells can efficiently replace central nervous system microglia, overcoming limitations of bone marrow transplantation. This microglia replacement by peripheral blood (Mr PB) strategy boosts donor cell availability for potential clinical applications.

Area of Science:

  • Neuroimmunology
  • Hematopoietic Stem Cell Transplantation

Background:

  • Microglia are crucial immune cells within the central nervous system.
  • Gene deficiencies in microglia can be corrected by replacing mutated cells with wild-type cells.
  • Current microglia replacement methods, like bone marrow transplantation, face limitations due to restricted donor cell availability.

Purpose of the Study:

  • To introduce a clinically feasible strategy for efficient microglia replacement using peripheral blood cells.
  • To enhance donor cell availability for microglia replacement therapies.
  • To present the microglia replacement by peripheral blood (Mr PB) protocol.

Main Methods:

  • Developed a novel protocol for microglia replacement utilizing peripheral blood cells in a mouse model.
  • The protocol, termed microglia replacement by peripheral blood (Mr PB), facilitates efficient cell engraftment.

Main Results:

  • Demonstrated efficient microglia replacement in the central nervous system using peripheral blood-derived cells.
  • The Mr PB strategy significantly increases the availability of donor cells compared to traditional bone marrow transplantation.

Conclusions:

  • Microglia replacement by peripheral blood (Mr PB) offers a promising, scalable alternative to bone marrow transplantation for correcting microglial gene deficiencies.
  • This approach holds potential for broader clinical application in treating neurological disorders.

Related Concept Videos